In Vivo Imaging of Tumor-Propagating Cells, Regional Tumor Heterogeneity, and Dynamic Cell Movements in Embryonal Rhabdomyosarcoma

Cancer Cell

Volumn 21, Issue 5, 2012, Pages 680-693

  Ignatius, Myron S ^a,b   Chen, Eleanor ^a,b,c   Elpek, Natalie M ^a   Fuller, Adam Z ^a,b   Tenente, Inês M ^a,b,d   Clagg, Ryan ^a,b   Liu, Sali ^a,b   Blackburn, Jessica S ^a,b   Linardic, Corinne M ^e   Rosenberg, Andrew E ^a   Nielsen, Petur G ^a   Mempel, Thorsten R ^a   Langenau, David M ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF PORTO   (Portugal)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOGENIC FACTOR 5; MYOGENIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONAL RHABDOMYOSARCOMA; IN VIVO STUDY; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; ZEBRA FISH;

DANIO RERIO;

EID: 84861401076     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.03.043     Document Type: Article

References (32)

1. Bentzinger C.F., Wang Y.X., Rudnicki M.A. Building muscle: molecular regulation of myogenesis. Cold Spring Harb. Perspect. Biol. 2012, 4:4.
2. Chen Y.H., Wang Y.H., Chang M.Y., Lin C.Y., Weng C.W., Westerfield M., Tsai H.J. Multiple upstream modules regulate zebrafish myf5 expression. BMC Dev. Biol. 2007, 7:1.
3. Conboy I.M., Conboy M.J., Smythe G.M., Rando T.A. Notch-mediated restoration of regenerative potential to aged muscle. Science 2003, 302:1575-1577.
4. Cooper R.N., Tajbakhsh S., Mouly V., Cossu G., Buckingham M., Butler-Browne G.S. In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J. Cell Sci. 1999, 112:2895-2901.
5. Dalerba P., Cho R.W., Clarke M.F. Cancer stem cells: models and concepts. Annu. Rev. Med. 2007, 58:267-284.
6. Du S.J., Gao J., Anyangwe V. Muscle-specific expression of myogenin in zebrafish embryos is controlled by multiple regulatory elements in the promoter. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2003, 134:123-134.
7. Eyler C.E., Wu Q., Yan K., MacSwords J.M., Chandler-Militello D., Misuraca K.L., Lathia J.D., Forrester M.T., Lee J., Stamler J.S., et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 2011, 146:53-66.
8. Gayraud-Morel B., Chrétien F., Tajbakhsh S. Skeletal muscle as a paradigm for regenerative biology and medicine. Regen. Med. 2009, 4:293-319.
9. Gilbertson R.J., Rich J.N. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat. Rev. Cancer 2007, 7:733-736.
10. Heerema-McKenney A., Wijnaendts L.C., Pulliam J.F., Lopez-Terrada D., McKenney J.K., Zhu S., Montgomery K., Mitchell J., Marinelli R.J., Hart A.A., et al. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype. Am. J. Surg. Pathol. 2008, 32:1513-1522.
11. Hettmer S., Liu J., Miller C.M., Lindsay M.C., Sparks C.A., Guertin D.A., Bronson R.T., Langenau D.M., Wagers A.J. Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells. Proc. Natl. Acad. Sci. USA 2011, 108:20002-20007.
12. Higashijima S., Okamoto H., Ueno N., Hotta Y., Eguchi G. High-frequency generation of transgenic zebrafish which reliably express GFP in whole muscles or the whole body by using promoters of zebrafish origin. Dev. Biol. 1997, 192:289-299.
13. Ju B., Chong S.W., He J., Wang X., Xu Y., Wan H., Tong Y., Yan T., Korzh V., Gong Z. Recapitulation of fast skeletal muscle development in zebrafish by transgenic expression of GFP under the mylz2 promoter. Dev. Dyn. 2003, 227:14-26.
14. Keller C., Arenkiel B.R., Coffin C.M., El-Bardeesy N., DePinho R.A., Capecchi M.R. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev. 2004, 18:2614-2626.
15. Langenau D.M., Keefe M.D., Storer N.Y., Guyon J.R., Kutok J.L., Le X., Goessling W., Neuberg D.S., Kunkel L.M., Zon L.I. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev. 2007, 21:1382-1395.
16. Langenau D.M., Keefe M.D., Storer N.Y., Jette C.A., Smith A.C., Ceol C.J., Bourque C., Look A.T., Zon L.I. Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish. Oncogene 2008, 27:4242-4248.
17. Lawson N.D., Weinstein B.M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 2002, 248:307-318.
18. Li Z., Bao S., Wu Q., Wang H., Eyler C., Sathornsumetee S., Shi Q., Cao Y., Lathia J., McLendon R.E., et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009, 15:501-513.
19. Linardic C.M., Downie D.L., Qualman S., Bentley R.C., Counter C.M. Genetic modeling of human rhabdomyosarcoma. Cancer Res. 2005, 65:4490-4495.
20. Lo Celso C., Fleming H.E., Wu J.W., Zhao C.X., Miake-Lye S., Fujisaki J., Côté D., Rowe D.W., Lin C.P., Scadden D.T. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 2009, 457:92-96.
21. McCroskery S., Thomas M., Maxwell L., Sharma M., Kambadur R. Myostatin negatively regulates satellite cell activation and self-renewal. J. Cell Biol. 2003, 162:1135-1147.
22. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., Weinberg R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
23. Polesskaya A., Seale P., Rudnicki M.A. Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell 2003, 113:841-852.
24. Rubin B.P., Nishijo K., Chen H.I., Yi X., Schuetze D.P., Pal R., Prajapati S.I., Abraham J., Arenkiel B.R., Chen Q.R., et al. Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell 2011, 19:177-191.
25. Rudnicki M.A., Schnegelsberg P.N., Stead R.H., Braun T., Arnold H.H., Jaenisch R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993, 75:1351-1359.
26. Seger C., Hargrave M., Wang X., Chai R.J., Elworthy S., Ingham P.W. Analysis of Pax7 expressing myogenic cells in zebrafish muscle development, injury, and models of disease. Dev. Dyn. 2011, 240:2440-2451.
27. Sipkins D.A., Wei X., Wu J.W., Runnels J.M., Côté D., Means T.K., Luster A.D., Scadden D.T., Lin C.P. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 2005, 435:969-973.
28. Smith A.C., Raimondi A.R., Salthouse C.D., Ignatius M.S., Blackburn J.S., Mizgirev I.V., Storer N.Y., de Jong J.L., Chen A.T., Zhou Y., et al. High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia. Blood 2010, 115:3296-3303.
29. Ustanina S., Carvajal J., Rigby P., Braun T. The myogenic factor Myf5 supports efficient skeletal muscle regeneration by enabling transient myoblast amplification. Stem Cells 2007, 25:2006-2016.
30. Wang Y., Kaiser M.S., Larson J.D., Nasevicius A., Clark K.J., Wadman S.A., Roberg-Perez S.E., Ekker S.C., Hackett P.B., McGrail M., Essner J.J. Moesin1 and Ve-cadherin are required in endothelial cells during in vivo tubulogenesis. Development 2010, 137:3119-3128.
31. Xia S.J., Pressey J.G., Barr F.G. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol. Ther. 2002, 1:97-104.
32. Zibat A., Missiaglia E., Rosenberger A., Pritchard-Jones K., Shipley J., Hahn H., Fulda S. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma. Oncogene 2010, 29:6323-6330.